Document Detail

Ovarian hyperstimulation syndrome prevention strategies: individualizing gonadotropin dose.
MedLine Citation:
PMID:  21082504     Owner:  NLM     Status:  In-Process    
The choice of the gonadotropin starting dose is an important parameter to prevent the onset of ovarian hyperstimulation syndrome (OHSS). The vast majority of studies available propose decreasing the gonadotropin starting dose, but conflicting results confirm that simply reducing the dose is not sufficient to prevent OHSS. True and dependable individualization of the gonadotropin starting dose is not yet possible. Attempts have been made to select parameters that predict ovarian response and to model them in a scoring system or algorithm that would result in a recommended gonadotropin starting dose. The CONSORT (CONsistency in r-FSH Starting dOses for individualized tReatmenT) dosing algorithm individualizes recombinant human follicle-stimulating hormone doses for assisted reproduction technologies, assigning 37.5-IU increments according to easily available patient characteristics (basal follicle-stimulating hormone, body mass index, age, and antral follicle count) that have been proven to accurately predict ovarian response to ovarian stimulation. The use of the CONSORT algorithm achieved an adequate oocyte yield and good pregnancy rates in a preliminary study. Results of a prospective randomized study are awaited to see if this tool would allow individualization of the gonadotropin starting dose.
François Olivennes
Related Documents :
19210924 - Interspecies embryo transfer in camelids: the birth of the first bactrian camel calves ...
9806564 - A comparative study of fixed-dose, step-down, and low-dose step-up regimens of human me...
2689484 - Influence of dexamethasone, progesterone, gonadotropin-releasing hormone, and testoster...
11121894 - The role of sub-optimal preovulatory oestradiol secretion in the aetiology of premature...
3914844 - Clindamycin for the treatment of falciparum malaria in sudan.
2207304 - Pharmacokinetics and safety of single oral doses of lomefloxacin.
Publication Detail:
Type:  Journal Article     Date:  2010-11-16
Journal Detail:
Title:  Seminars in reproductive medicine     Volume:  28     ISSN:  1526-4564     ISO Abbreviation:  Semin. Reprod. Med.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-11-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100909394     Medline TA:  Semin Reprod Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  463-7     Citation Subset:  IM    
Copyright Information:
© Thieme Medical Publishers.
IVF center Eylau La Muette, Paris, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Identification of the high-risk patient for ovarian hyperstimulation syndrome.
Next Document:  Ovarian hyperstimulation syndrome prevention strategies: oral contraceptive pills-dual gonadotropin-...